U.S. Physical Therapy (NYSE:USPH) Posts Quarterly Earnings Results

U.S. Physical Therapy (NYSE:USPH) announced its quarterly earnings data on Wednesday. The company reported $0.75 earnings per share for the quarter, missing the consensus estimate of $0.81 by ($0.06), Zacks reports. U.S. Physical Therapy had a return on equity of 9.22% and a net margin of 3.97%.The firm had revenue of $214.06 million during the quarter, compared to analysts’ expectations of $211.36 million. During the same period last year, the business posted $0.81 EPS. The company’s revenue was up 8.5% compared to the same quarter last year.

U.S. Physical Therapy Stock Up 2.8%

NYSE:USPH traded up $2.13 on Friday, reaching $78.59. 110,379 shares of the stock traded hands, compared to its average volume of 215,992. The company’s fifty day simple moving average is $69.86 and its 200 day simple moving average is $74.19. The company has a market capitalization of $1.20 billion, a price-to-earnings ratio of 462.53, a PEG ratio of 2.15 and a beta of 1.13. U.S. Physical Therapy has a 12 month low of $58.19 and a 12 month high of $93.50. The company has a current ratio of 1.19, a quick ratio of 1.19 and a debt-to-equity ratio of 0.41.

U.S. Physical Therapy Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, September 11th. Shareholders of record on Friday, August 21st will be paid a dividend of $0.46 per share. This represents a $1.84 dividend on an annualized basis and a yield of 2.3%. The ex-dividend date is Friday, August 21st. U.S. Physical Therapy’s dividend payout ratio (DPR) is currently 368.00%.

Insider Buying and Selling at U.S. Physical Therapy

In other news, Director Peter Francis Minan acquired 492 shares of the firm’s stock in a transaction that occurred on Monday, June 8th. The stock was bought at an average cost of $63.14 per share, for a total transaction of $31,064.88. Following the acquisition, the director directly owned 2,923 shares in the company, valued at approximately $184,558.22. The trade was a 20.24% increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which can be accessed through this link. 2.40% of the stock is owned by company insiders.

Institutional Inflows and Outflows

A number of institutional investors have recently bought and sold shares of USPH. Bank of America Corp DE raised its stake in shares of U.S. Physical Therapy by 77.2% in the third quarter. Bank of America Corp DE now owns 317,200 shares of the company’s stock worth $26,946,000 after buying an additional 138,194 shares during the period. Schroder Investment Management Group grew its stake in shares of U.S. Physical Therapy by 45.9% during the 4th quarter. Schroder Investment Management Group now owns 364,253 shares of the company’s stock valued at $29,603,000 after acquiring an additional 114,618 shares during the period. 4D Advisors LLC purchased a new stake in U.S. Physical Therapy in the 3rd quarter worth approximately $9,344,000. First Trust Advisors LP increased its holdings in U.S. Physical Therapy by 607.2% in the 4th quarter. First Trust Advisors LP now owns 69,834 shares of the company’s stock worth $5,453,000 after acquiring an additional 59,959 shares in the last quarter. Finally, Two Sigma Investments LP raised its stake in U.S. Physical Therapy by 718.8% during the 3rd quarter. Two Sigma Investments LP now owns 60,267 shares of the company’s stock worth $5,120,000 after acquiring an additional 52,907 shares during the period.

Analyst Ratings Changes

Several research analysts have commented on the stock. Citigroup reissued a “market outperform” rating on shares of U.S. Physical Therapy in a report on Friday, July 24th. Zacks Research upgraded U.S. Physical Therapy from a “strong sell” rating to a “hold” rating in a research report on Wednesday, May 27th. Citizens Jmp reissued a “market outperform” rating and issued a $98.00 price target on shares of U.S. Physical Therapy in a research note on Wednesday, June 24th. Barrington Research dropped their price target on U.S. Physical Therapy from $103.00 to $90.00 and set an “outperform” rating for the company in a research note on Wednesday, May 13th. Finally, Weiss Ratings reiterated a “hold (c-)” rating on shares of U.S. Physical Therapy in a research report on Friday, May 29th. One equities research analyst has rated the stock with a Strong Buy rating, four have given a Buy rating and two have given a Hold rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $97.50.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc (NYSE: USPH) is a leading owner and operator of outpatient physical therapy clinics across the United States. The company delivers rehabilitative care to patients recovering from orthopedic injuries, neurological disorders and chronic conditions. Its core services include one-on-one physical therapy sessions, aquatic therapy, occupational therapy, massage therapy and sports medicine programs designed to restore mobility and enhance quality of life.

In addition to traditional rehabilitation services, U.S.